PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1125306
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1125306
Global Interventional Oncology Market Size study, By Product (Ablation, Particle Embolization, Support Devices), and Regional Forecasts 2022-2028
Global Interventional Oncology Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028.
The Interventional Oncology can be defined as a cancer treatment procedure with minimally invasive techniques in the management of cancer. In Interventional procedure an oncologist performs diagnostic procedures, such as colonoscopies or endoscopies, X-ray, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) to enable targeted and precise treatment of cancer tumours. The growing penetration of Cancer worldwide and increasing demand for minimally invasive treatment procedures as well as recent collaboration activities from leading market players are factors that are accelerating the global market demand. For instance, according to World Cancer Research Fund International estimates - as of 2020, around 18.1 million cancer cases were estimated worldwide. Out of these, 9.3 million cases were reported in men and around 8.8 million reported in women. Breast and lung cancers were the most common cancers worldwide, accounting for 12.5% (2.26 million) and 12.2% (2.20 million) of the total number of new cases diagnosed in 2020. Furthermore, leading market players are working towards strategic partnerships and collaborations to develop interventional oncology solutions. For instance, in July 2021, Medical technology firm Terumo Europe and University Medical Centre Utrecht (UMCU) entered in a memorandum of understanding (MoU) to extend their partnership in the field of oncology. Also, growing number of R&D activities towards new cancer therapeutics as well as rising healthcare infrastructure in emerging economies are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, inadequate distribution of funds for the research purpose, and earth of skilled professionals impede the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Interventional Oncology Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing number of research and development activities and presence of leading cancer care centers in the region. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as growing healthcare sector and increasing incidences of cancer cases in the region, would create lucrative growth prospects for the global Interventional Oncology Market across the Asia Pacific region.
Major market players included in this report are:
Alpinion Medical Systems Co. Ltd.
AngioDynamics
Boston Scientific Corporation
Hologic, Inc.
Medtronic Plc.
Merit Medical
Profound Medical
Siemens Healthineers
Teleflex Incorporated
Terumo Corporation
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product
Ablation
Particle Embolization
Support Devices
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Interventional Oncology Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
- 1.2.1. Global Interventional Oncology Market, by Region, 2020-2028 (USD Million)
- 1.2.2. Global Interventional Oncology Market, by Product, 2020-2028 (USD Million)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Interventional Oncology Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Interventional Oncology Market Dynamics
- 3.1. Interventional Oncology Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. Growing penetration of Cancer worldwide.
- 3.1.1.2. Increasing demand for minimally invasive treatment procedures.
- 3.1.1.3. Recent collaboration activities from leading market players.
- 3.1.2. Market Challenges
- 3.1.2.1. Inadequate distribution of funds for the research purpose
- 3.1.2.2. Dearth of skilled professionals.
- 3.1.3. Market Opportunities
- 3.1.3.1. Growing number of R&D activities towards new cancer therapeutics.
- 3.1.3.2. Rising healthcare infrastructure in emerging economies.
- 3.1.1. Market Drivers
Chapter 4. Global Interventional Oncology Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Interventional Oncology Market, by Product
- 6.1. Market Snapshot
- 6.2. Global Interventional Oncology Market by Product, Performance - Potential Analysis
- 6.3. Global Interventional Oncology Market Estimates & Forecasts by Product 2018-2028 (USD Million)
- 6.4. Interventional Oncology Market, Sub Segment Analysis
- 6.4.1. Ablation
- 6.4.2. Particle Embolization
- 6.4.3. Support Devices
Chapter 7. Global Interventional Oncology Market, Regional Analysis
- 7.1. Interventional Oncology Market, Regional Market Snapshot
- 7.2. North America Interventional Oncology Market
- 7.2.1. U.S. Interventional Oncology Market
- 7.2.1.1. Product estimates & forecasts, 2018-2028
- 7.2.2. Canada Interventional Oncology Market
- 7.2.1. U.S. Interventional Oncology Market
- 7.3. Europe Interventional Oncology Market Snapshot
- 7.3.1. U.K. Interventional Oncology Market
- 7.3.2. Germany Interventional Oncology Market
- 7.3.3. France Interventional Oncology Market
- 7.3.4. Spain Interventional Oncology Market
- 7.3.5. Italy Interventional Oncology Market
- 7.3.6. Rest of Europe Interventional Oncology Market
- 7.4. Asia-Pacific Interventional Oncology Market Snapshot
- 7.4.1. China Interventional Oncology Market
- 7.4.2. India Interventional Oncology Market
- 7.4.3. Japan Interventional Oncology Market
- 7.4.4. Australia Interventional Oncology Market
- 7.4.5. South Korea Interventional Oncology Market
- 7.4.6. Rest of Asia Pacific Interventional Oncology Market
- 7.5. Latin America Interventional Oncology Market Snapshot
- 7.5.1. Brazil Interventional Oncology Market
- 7.5.2. Mexico Interventional Oncology Market
- 7.6. Rest of The World Interventional Oncology Market
Chapter 8. Competitive Intelligence
- 8.1. Top Market Strategies
- 8.2. Company Profiles
- 8.2.1. Alpinion Medical Systems Co. Ltd.
- 8.2.1.1. Key Information
- 8.2.1.2. Overview
- 8.2.1.3. Financial (Subject to Data Availability)
- 8.2.1.4. Product Summary
- 8.2.1.5. Recent Developments
- 8.2.2. AngioDynamics
- 8.2.3. Boston Scientific Corporation
- 8.2.4. Hologic, Inc.
- 8.2.5. Medtronic Plc.
- 8.2.6. Merit Medical
- 8.2.7. Profound Medical
- 8.2.8. Siemens Healthineers
- 8.2.9. Teleflex Incorporated
- 8.2.10. Terumo Corporation
- 8.2.1. Alpinion Medical Systems Co. Ltd.
Chapter 9. Research Process
- 9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
- 9.2. Research Attributes
- 9.3. Research Assumption
LIST OF TABLES
- TABLE 1. Global Interventional Oncology Market, report scope
- TABLE 2. Global Interventional Oncology Market estimates & forecasts by Region 2018-2028 (USD Million)
- TABLE 3. Global Interventional Oncology Market estimates & forecasts by Product 2018-2028 (USD Million)
- TABLE 4. Global Interventional Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
- TABLE 5. Global Interventional Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
- TABLE 6. Global Interventional Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
- TABLE 7. Global Interventional Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
- TABLE 8. Global Interventional Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
- TABLE 9. Global Interventional Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
- TABLE 10. Global Interventional Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
- TABLE 11. Global Interventional Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
- TABLE 12. Global Interventional Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
- TABLE 13. Global Interventional Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
- TABLE 14. U.S. Interventional Oncology Market estimates & forecasts, 2018-2028 (USD Million)
- TABLE 15. U.S. Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 16. U.S. Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 17. Canada Interventional Oncology Market estimates & forecasts, 2018-2028 (USD Million)
- TABLE 18. Canada Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 19. Canada Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 20. UK Interventional Oncology Market estimates & forecasts, 2018-2028 (USD Million)
- TABLE 21. UK Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 22. UK Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 23. Germany Interventional Oncology Market estimates & forecasts, 2018-2028 (USD Million)
- TABLE 24. Germany Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 25. Germany Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 26. RoE Interventional Oncology Market estimates & forecasts, 2018-2028 (USD Million)
- TABLE 27. RoE Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 28. RoE Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 29. China Interventional Oncology Market estimates & forecasts, 2018-2028 (USD Million)
- TABLE 30. China Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 31. China Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 32. India Interventional Oncology Market estimates & forecasts, 2018-2028 (USD Million)
- TABLE 33. India Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 34. India Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 35. Japan Interventional Oncology Market estimates & forecasts, 2018-2028 (USD Million)
- TABLE 36. Japan Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 37. Japan Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 38. RoAPAC Interventional Oncology Market estimates & forecasts, 2018-2028 (USD Million)
- TABLE 39. RoAPAC Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 40. RoAPAC Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 41. Brazil Interventional Oncology Market estimates & forecasts, 2018-2028 (USD Million)
- TABLE 42. Brazil Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 43. Brazil Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 44. Mexico Interventional Oncology Market estimates & forecasts, 2018-2028 (USD Million)
- TABLE 45. Mexico Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 46. Mexico Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 47. RoLA Interventional Oncology Market estimates & forecasts, 2018-2028 (USD Million)
- TABLE 48. RoLA Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 49. RoLA Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 50. Row Interventional Oncology Market estimates & forecasts, 2018-2028 (USD Million)
- TABLE 51. Row Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 52. Row Interventional Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
- TABLE 53. List of secondary sources, used in the study of global Interventional Oncology Market
- TABLE 54. List of primary sources, used in the study of global Interventional Oncology Market
- TABLE 55. Years considered for the study
- TABLE 56. Exchange rates considered
LIST OF FIGURES
List of figures
- FIG 1. Global Interventional Oncology Market, research methodology
- FIG 2. Global Interventional Oncology Market, Market estimation techniques
- FIG 3. Global Market size estimates & forecast methods
- FIG 4. Global Interventional Oncology Market, key trends 2021
- FIG 5. Global Interventional Oncology Market, growth prospects 2022-2028
- FIG 6. Global Interventional Oncology Market, porters 5 force model
- FIG 7. Global Interventional Oncology Market, pest analysis
- FIG 8. Global Interventional Oncology Market, value chain analysis
- FIG 9. Global Interventional Oncology Market by segment, 2018 & 2028 (USD Million)
- FIG 10. Global Interventional Oncology Market by segment, 2018 & 2028 (USD Million)
- FIG 11. Global Interventional Oncology Market by segment, 2018 & 2028 (USD Million)
- FIG 12. Global Interventional Oncology Market by segment, 2018 & 2028 (USD Million)
- FIG 13. Global Interventional Oncology Market by segment, 2018 & 2028 (USD Million)
- FIG 14. Global Interventional Oncology Market, regional snapshot 2018 & 2028
- FIG 15. North America Interventional Oncology Market 2018 & 2028 (USD Million)
- FIG 16. Europe Interventional Oncology Market 2018 & 2028 (USD Million)
- FIG 17. Asia pacific Market 2018 & 2028 (USD Million)
- FIG 18. Latin America Interventional Oncology Market 2018 & 2028 (USD Million)
- FIG 19. Global Interventional Oncology Market, company Market share analysis (2021)
